RESUMO
In order to defined the PO theophylline dose which produced effective theophylline concentrations between 4-10 micrograms/ml in prematures babies, we analized the theophylline pharmacokinetic of 6 adequate weight for gestational age female prematures, aged 31-34 gestational weeks, to which we administered PO 5 mg/kg of theophylline as the attack dose, following by a PO maintained dose of 2.5 mg/kg/12 h. In steady-state we did the pharmacokinetic studies after the administration of one dose. We found that only maintenance doses of 2.5 mg/kg/12 h produced therapeutic theophylline concentrations. Considering the pharmacokinetic data, we conclude that PO maintenance dose of 3 mg/kg/12 h of theophylline will be necessary to reach effective theophylline concentration.
Assuntos
Apneia/sangue , Asfixia Neonatal/sangue , Doenças do Prematuro/sangue , Teofilina/sangue , Humanos , Recém-Nascido , Monitorização FisiológicaRESUMO
In order to defined the theophylline dose which produce effective theophylline concentrations with less number of plasmatic controls, we analyzed the theophylline pharmacokinetics of 18 boys and girls between 3-12 year olds of Tarragona, to which we administered 6 mg/kg/6 h of aminophylline by IV intermittent infusion (30 min), following by rapid-release PO aminophylline at the same dose and intervals. In steady-state we did the pharmacokinetic studies at 1 h, 4 h and 6 h after the administration of one dose. The maintenance dose obtained was administered PO as slow-release theophylline, with later controls of theophylline concentration. We found that maintenance dose of 24.1 +/- 4.7 mg/kg/day (mean +/- SD) allowed theophylline concentration between therapeutic levels in the population studied.